Multicenter in vitro evaluation of SM-7338, a new carbapenem.

A new carbapenem, SM-7338, was compared with imipenem, cefotaxime, and ceftazidime at five medical centers. Nearly 6,000 strains were tested by reference methods of the National Committee for Clinical Laboratory Standards, and SM-7338 inhibited the largest percentage of gram-negative bacilli. Its sp...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Jones, R N, Aldridge, K E, Allen, S D, Barry, A L, Fuchs, P C, Gerlach, E H, Pfaller, M A
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1989
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172479/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2658796/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.4.562
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!